1. Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders

    Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders

    Bristol-Myers Squibb Company’s BMY, -1.55% Board of Directors today sent an open letter to the Company’s shareholders regarding the previously announced definitive merger agreement with Celgene Corporation CELG, -1.65% In addition to its March 19 investor presentation, the Company today also made available on Bristol-Myers Squibb’s website ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned